IHC3 is a competitive and reversible monoamine oxidase B (MAO-B) inhibitor with an IC50 of 1.672 µM, targeting Cys172 within the enzymes active site, used in the study of neurological diseases [1].
Molecular Weight:
293.3
Formula:
C17H12FN3O
Target:
Monoamine Oxidase
* VAT and and shipping costs not included. Errors and price changes excepted
